Preliminary Results of the Oral CD73 Inhibitor, Oric-533, in Relapsed/Refractory Multiple Myeloma (RRMM)

Rodriguez, C; Solomon, SR; Paul, B; Nadeem, O; Patel, M; Wang, J; Xu, RD; Junttila, M; Daemen, A; Katewa, S; Multani, PS; Gonsalves, WI

BLOOD, 2023; 142 ():